Estève Emmanuel, Krug Pauline, Hummel Aurélie, Arnoux Jean-Baptiste, Boyer Olivia, Brassier Anais, de Lonlay Pascale, Vuiblet Vincent, Gobin Stéphanie, Salomon Rémi, Piètrement Christine, Bonnefont Jean-Paul, Servais Aude, Galmiche Louise
Pathology Department Hôpital Necker-Enfants Malades, Assistance Publique, Hôpitaux de Paris, Université Sorbonne Paris Cité, 75015, Paris, France.
Pediatric Nephrology Department, Hôpital Necker-Enfants Malades, Assistance Publique, Hôpitaux de Paris, Université Sorbonne Paris Cité, 75015, Paris, France.
Hum Pathol. 2017 Apr;62:160-169. doi: 10.1016/j.humpath.2016.12.021. Epub 2017 Jan 11.
Lysinuric protein intolerance (LPI) is a rare autosomal recessive disease caused by mutations in the SLC7A7 gene encoding the light subunit of a cationic amino acid transporter. Symptoms mimic primary urea cycle defects but dysimmune symptoms are also described. Renal involvement in LPI was first described in the 1980s. In 2007, it appeared that it could concern as much as 75% of LPI patients and could lead to end-stage renal disease. The most common feature is proximal tubular dysfunction and nephrocalcinosis but glomerular lesions are also reported. However, very little is known regarding histological lesions associated with LPI. We gathered every kidney biopsy of LPI-proven patients in our highly specialized pediatric and adult institution. Clinical, biological, and histological information was analyzed. Five LPI patients underwent kidney biopsy in our institution between 1986 and 2015. Clinically, 4/5 presented with proximal tubular dysfunction and 3/5 with nephrotic range proteinuria. Histology showed unspecific tubulointerstitial lesions and nephrocalcinosis in 3/5 biopsies and marked peritubular capillaritis in one child. Glomerular lesions were heterogeneous: lupus-like-full house membranoproliferative glomerulonephritis (MPGN) in one child evolved towards monotypic IgG1κ MPGN sensitive to immunomodulators. One patient presented with glomerular non-AA non-AL amyloidosis. Renal biopsy is particularly relevant in LPI presenting with glomerular symptoms for which variable histological lesions can be responsible, implying specific treatment and follow-up.
赖氨酸尿性蛋白不耐受症(LPI)是一种罕见的常染色体隐性疾病,由编码阳离子氨基酸转运体轻链亚基的SLC7A7基因突变引起。其症状类似原发性尿素循环缺陷,但也有免疫功能紊乱症状的描述。LPI患者的肾脏受累情况最早于20世纪80年代被描述。2007年发现,多达75%的LPI患者可能出现肾脏受累,并且可能导致终末期肾病。最常见的特征是近端肾小管功能障碍和肾钙质沉着症,但也有肾小球病变的报道。然而,关于与LPI相关的组织学病变知之甚少。我们收集了在我们高度专业化的儿科和成人机构确诊为LPI患者的每一份肾活检样本。对临床、生物学和组织学信息进行了分析。1986年至2015年间,有5例LPI患者在我们机构接受了肾活检。临床上,5例中有4例表现为近端肾小管功能障碍,5例中有3例表现为肾病范围蛋白尿。组织学检查显示,5份活检样本中有3份出现非特异性肾小管间质病变和肾钙质沉着症,1名儿童出现明显的肾小管周围毛细血管炎。肾小球病变具有异质性:1名儿童的狼疮样满堂亮膜增生性肾小球肾炎(MPGN)演变为对免疫调节剂敏感的单型IgG1κ MPGN。1例患者出现肾小球非AA非AL淀粉样变性。对于出现肾小球症状的LPI患者,肾活检尤为重要,因为多种组织学病变可能是其病因,这意味着需要特定的治疗和随访。